Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 49 clinical trials
A Multicenter Study of Active Specific Immunotherapy With OncoVax in Patients With Stage II Colon Cancer

OncoVAX is the first cancer vaccine that both prevents cancer recurrence and addresses the diversity of cancer cells. In this pivotal randomized, multicenter Phase IIIb study in patients with Stage II colon cancer, OncoVAX is designed to use a patient's own cancer cells to mobilize the body's immune system to …

  • 0 views
  • 21 Jan, 2021
  • 1 location
Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNA

Circulating tumor DNA (ctDNA) is a highly specific and effective biomarker for the detection of EGFR mutation status. We hypothesise AZD9291 is efficacious in patients with EGFR sensitizing mutations and T790M detected in plasma ctDNA. This is a prospective, open label, multi-centre single arm phase II study assessing the efficacy …

platelet count
stage iv non-small cell lung cancer
follicle stimulating hormone
ct scan
EGFR
  • 46 views
  • 08 Nov, 2020
  • 4 locations
Adjuvant IFN- for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression

The purpose of the study is to determine whether interferon-alpha is effective in prevention of tumor recurrence for the patients with a low miR-26 expression in tumor after curative resection of hepatocellular carcinoma.

thrombosis
metastasis
interferon
  • 0 views
  • 08 Nov, 2020
  • 3 locations
Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery

In Israel, of the ~1000 patients diagnosed annually with pancreatic cancer (PC), approximately 250 (25 percent) will be eligible for curative surgery, of which 80 percent will succumb to post

metastasis
adenocarcinoma
  • 9 views
  • 25 Nov, 2019
  • 3 locations
Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer

Rationale: Adjuvant chemoradiation considered as standard of care after curative surgery for adenocarcinoma of stomach and gastroesophageal cancer. Preoperative chemotherapy in the in

curative surgery
gastric cancer
gastric adenocarcinoma
carcinoma
cancer
  • 12 views
  • 07 Nov, 2020
  • 1 location
Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer

undergone curative surgery without residual cancer using 3-year disease free survival (DFS) as the primary endpoint, and also to analyze the 3-year overall survival (OS), compliance, adverse

platelet count
leucovorin
adenocarcinoma
rectal carcinoma
calcium
  • 4 views
  • 07 Nov, 2020
  • 1 location
Proton Radiation for Unresectable Borderline Resectable or Medically Inoperable Carcinoma of the Pancreas

the share of patients able to undergo curative surgery and 2.) Improve the local disease control interval and extend survival for patients who remain unresectable. Therefore, the purpose of this

platelet count
carcinoma
adenocarcinoma
drainage
capecitabine
  • 25 views
  • 15 Jul, 2019
  • 1 location
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

I non-small cell lung cancer is generally greater than 50% after surgery. Many of these patients have heart and lung issues or other diseases which keep them from undergoing curative surgery

carcinoma
cancer chemotherapy
carboplatin
carboplatin/paclitaxel
lung carcinoma
  • 18 views
  • 08 Nov, 2020
  • 1 location
  • 6 views
  • 08 Nov, 2020
  • 1 location
Colorectal Metastasis Prevention International Trial 2

trial in 200 colorectal cancer patients undergoing curative surgery in Israel. A perioperative 20-day drug treatment will be initiated 5 days before surgery. Primary outcomes will include (i) 3-year

rectal carcinoma
metastasis
carcinoma
  • 7 views
  • 21 Apr, 2019
  • 3 locations